Royal Victoria Infirmary, Newcastle upon Tyne, UK
Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Search for other papers by Leonidas H. Duntas in
Google Scholar
PubMed
Search for other papers by Fabio Monzani in
Google Scholar
PubMed
Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
Queen Elizabeth Hospital, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
questions have prompted the European Thyroid Association (ETA) to form a task force with the aim of drawing up guidelines on the management of SCH in adults. A specific guideline on the management of SCH in children and in pregnancy will be prepared
Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Simon P. Mooijaart in
Google Scholar
PubMed
Dear Editor, In this letter we would like to emphasize a specific part of the new ETA guideline which was explained in the paper by Pearce et al. [ 1 ], more specifically the part on thyroid hormone supplementation in the oldest old. In
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
the ETA guideline’s ability to predict the growth and persistence of POU findings in patients with or without neck dissection and/or radioiodine-remnant ablation (RAI) found significantly lower rates of growth and persistence for ETA indeterminate
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
Editorial Board Members and Associate Editors, as well as the real constituency of the Journal, those experts who have reviewed papers, ETA Guideline authors and authors who have contributed to the journal. Simon H. Pearce , Editor in Chief Wilmar
Search for other papers by David J. Stott in
Google Scholar
PubMed
Search for other papers by Douglas C. Bauer in
Google Scholar
PubMed
Search for other papers by Ian Ford in
Google Scholar
PubMed
Search for other papers by Patricia Kearney in
Google Scholar
PubMed
Search for other papers by Jacobijn Gussekloo in
Google Scholar
PubMed
Search for other papers by Terence J. Quinn in
Google Scholar
PubMed
Search for other papers by Nicolas Rodondi in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
Search for other papers by Rudi Westerdorp in
Google Scholar
PubMed
Dear Editor, The recent European Thyroid Association (ETA) guideline on the treatment of subclinical hypothyroidism (SCH) [ 1 ] will potentially be widely used by clinicians faced with this common condition. Although the report includes much
Search for other papers by Alex Stagnaro-Green in
Google Scholar
PubMed
the last 3 years, that the guidelines developed by the European Thyroid Association (ETA) should be evaluated [ 4 ]. The ETA clinical guidelines, established by a distinguished panel of experts in the field of thyroid and pregnancy, and entitled
Search for other papers by Richard T. Kloos in
Google Scholar
PubMed
Introduction The European Thyroid Association (ETA) launched a taskforce, chaired by Martin Schlumberger, to create guidelines on the treatment of metastatic medullary thyroid cancer (MTC) [ 1 ]. The decision to create a focused guideline
Search for other papers by Leonidas H. Duntas in
Google Scholar
PubMed
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Search for other papers by Fabio Monzani in
Google Scholar
PubMed
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed
Search for other papers by Robin Patrick Peeters in
Google Scholar
PubMed
Queen Elizabeth Hospital, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
.1159/000360621 2 Pearce SHS, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL: 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J 2013;2:215-228. 10.1159/000356507 24783053 3 Vanderpump MP, Tunbridge WM, French JM
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
Search for other papers by Jonathan D Wasserman in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
Nodule and Differentiated Thyroid Cancer Guidelines as the framework and built upon these through a rigorous literature review, including the application of PICOTS methodology ( 6 ) (defined by the European Thyroid Association (ETA) as ‘population
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Kristian H. Winther in
Google Scholar
PubMed
Association (ETA) have previously dealt with diagnostic and therapeutic aspects of GD and GO, but not focused on the potential role of the trace element selenium (Se) [ 7 , 8 ]. Se is a non-metal trace element, essential for the production of selenoproteins
